Caliway Announces CBL-514 Phase 2 Study Topline Results for Dercum’s Disease, Showing 64.5% of Lipomas with Complete Clearance or Dimensions Reduction of Over 50% and Reduced Pain by 4.7

– CBL-0201DD Phase 2 study met the primary and all secondary endpoints. – 64.5% of painful lipomas showed complete clearance or dimensions reduction of more than 50% after CBL-514 treatments. – 54.8% of painful lipomas showed complete clearance or dimension reduction of more than 50%…